is a US-based company engaged in the production of semaglutide
The FDA accepted it for filing on April 1, and by that announcement Repros had already dropped the brand, calling it its enclomiphene citrate product candidate, formerly known as Androxal. The indication it sought was narrower than anyone remembers, and the FDA wrote it out in full: NDA 207959, enclomiphene citrate 12.5 mg and 25 mg capsules, for the proposed treatment of secondary hypogonadism in fertile men (men with more than 15 million sperm/milliliter (ml)), younger than 60 years of age with a Body Mass Index (BMI) over 25 kilograms (kg)/meters squared (m2) (80 FR 50639)
The statements made on this website have not been evaluated by the Food & Drug Administration
Android Developers
Ensuring adequate nutrition, particularly B vitamins, is an important part of managing and preventing skin sensitivity
As both a medical weight loss clinic and a medical spa, we are uniquely positioned to help you lose weight and keep it off
